학술논문
The safety, efficacy, and pharmacokinetic profile of a switch in antiretroviral therapy to saquinavir, ritonavir, and atazanavir alone for 48 weeks and a switch in the saquinavir formulation
Document Type
Academic Journal
Author
Source
Clinical Infectious Diseases. June 1, 2007, Vol. 44 Issue 11, p1475, 9 p.
Subject
Language
English
ISSN
1058-4838